KQSSKALQR is a BCR-ABL peptide. KQSSKALQR can induce CD8+T cell responses. KQSSKALQR can be used in vaccine research for chronic myeloid leukaemia (CML)[1].
Molecular Weight:
1045.19
CAS Number:
[164031-33-8]
Formula:
C43H80N16O14
Target:
Others
Application Notes:
MCE Product type: Peptides
* VAT and and shipping costs not included. Errors and price changes excepted